Core Laboratories Inc. $CLB Shares Sold by Royce & Associates LP

Royce & Associates LP trimmed its stake in Core Laboratories Inc. (NYSE:CLB) by 53.1% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 206,716 shares of the oil and gas company’s stock after selling 233,726 shares during the quarter. Royce & Associates LP owned approximately 0.44% of Core Laboratories worth $3,314,000 at the end of the most recent quarter.

Other hedge funds have also modified their holdings of the company. CWM LLC grew its holdings in shares of Core Laboratories by 36.1% in the 4th quarter. CWM LLC now owns 2,516 shares of the oil and gas company’s stock worth $40,000 after acquiring an additional 668 shares during the last quarter. Quarry LP grew its holdings in shares of Core Laboratories by 118.1% in the 3rd quarter. Quarry LP now owns 2,953 shares of the oil and gas company’s stock worth $36,000 after acquiring an additional 1,599 shares during the last quarter. Hantz Financial Services Inc. grew its holdings in shares of Core Laboratories by 124.7% in the 4th quarter. Hantz Financial Services Inc. now owns 3,177 shares of the oil and gas company’s stock worth $51,000 after acquiring an additional 1,763 shares during the last quarter. GAMMA Investing LLC grew its holdings in shares of Core Laboratories by 73.3% in the 4th quarter. GAMMA Investing LLC now owns 5,157 shares of the oil and gas company’s stock worth $83,000 after acquiring an additional 2,181 shares during the last quarter. Finally, Tower Research Capital LLC TRC grew its holdings in shares of Core Laboratories by 400.9% in the 2nd quarter. Tower Research Capital LLC TRC now owns 7,333 shares of the oil and gas company’s stock worth $84,000 after acquiring an additional 5,869 shares during the last quarter. 97.81% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities analysts recently issued reports on the company. Weiss Ratings cut Core Laboratories from a “hold (c)” rating to a “hold (c-)” rating in a report on Monday, May 4th. Wall Street Zen downgraded Core Laboratories from a “hold” rating to a “sell” rating in a report on Monday, May 25th. Three analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $12.00.

Core Laboratories Stock Performance

Shares of NYSE CLB opened at $13.65 on Friday. Core Laboratories Inc. has a one year low of $9.72 and a one year high of $20.36. The business’s 50-day moving average price is $15.51 and its two-hundred day moving average price is $16.61. The company has a market capitalization of $629.27 million, a P/E ratio of 21.00, a price-to-earnings-growth ratio of 2.69 and a beta of 0.99. The company has a debt-to-equity ratio of 0.42, a current ratio of 2.05 and a quick ratio of 1.50.

Core Laboratories (NYSE:CLB) last released its quarterly earnings results on Wednesday, April 29th. The oil and gas company reported $0.06 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.06. The company had revenue of $121.80 million during the quarter, compared to the consensus estimate of $122.99 million. Core Laboratories had a return on equity of 11.52% and a net margin of 5.94%.The firm’s revenue was down 1.4% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.14 EPS. Core Laboratories has set its Q2 2026 guidance at 0.060-0.120 EPS. Analysts anticipate that Core Laboratories Inc. will post 0.56 earnings per share for the current fiscal year.

Core Laboratories Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, June 1st. Stockholders of record on Monday, May 11th will be paid a dividend of $0.01 per share. This represents a $0.04 annualized dividend and a dividend yield of 0.3%. The ex-dividend date is Monday, May 11th. Core Laboratories’s dividend payout ratio is 6.15%.

About Core Laboratories

Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets.

The company’s portfolio spans two primary service lines: reservoir description and production enhancement.